Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy

Current Opinion in Cardiology

Volumn 22, Issue 1, 2007, Pages 25-32

  Chauhan, Vijay S ^a,b   Selvaraj, Raja J ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cardiomyopathy; Risk stratification; T wave alternans

Indexed keywords

CARDIOMYOPATHY; DEFIBRILLATOR; EXERCISE TEST; HEART ATRIUM PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUDDEN DEATH; T WAVE; T WAVE ALTERNANS;

ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR FIBRILLATION;

EID: 33845388443     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328011aa49     Document Type: Review

References (51)

1. Podrid PJ, Myerburg RJ. Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 2005; 28:I3-I11.
2. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005; 112:3738-3744.
3. MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
4. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
6. Buxton AE. Identifying the high risk patient with coronary artery disease: Is ejection fraction all you need? J Cardiovasc Electrophysiol 2005; 16 (Suppl 1):S25-S27. Discusses the limitations of using ejection fraction as the sole marker of sudden death risk.
7. Pastore JM, Girouard SD, Laurita KR, et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999; 99:1385-1394.
8. Wan X, Laurita KR, Pruvot EJ, Rosenbaum DS. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol 2005; 39:419-428. Demonstrates the importance of calcium alternans in the genesis of APD alternans as well as the mechanisms of APD alternans related to arrhythmogenesis.
9. Walker ML, Wan X, Kirsch GE, Rosenbaum DS. Hysteresis effect implicates calcium cycling as a mechanism of repolarization alternans. Circulation 2003; 108:2704-2709.
10. Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res 2004; 94:1083-1090.
11. Goldhaber JI, Xie LH, Duong T, et al. Action potential duration restitution and alternans in rabbit ventricular myocytes: The key role of intracellular calcium cycling. Circ Res 2005; 96:459-466. Demonstrates the relative contribution of APD restitution versus calcium cycling in the pathogenesis of alternans.
12. Koller ML, Maier SK, Gelzer AR, et al. Altered dynamics of action potential restitution and alternans in humans with structural heart disease. Circulation 2005; 112:1542-1548. Demonstrates the importance of APD restitution in the genesis of alternans in patients with relatively preserved ventricular function.
13. Wu R, Patwardhan A. Mechanism of repolarization alternans has restitution of action potential duration dependent and independent components. J Cardiovasc Electrophysiol 2006; 17:87-93.
14. Selvaraj RJ, Picton P, Nanthakumar K, et al. Endocardial and epicardial repolarization alternans in human cardiomyopathy: Evidence for spatiotemporal heterogeneity and discordance. J Am Coll Cardiol (in press).
15. Shusterman V, Goldberg A, London B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation 2006; 113:2880-2887. The first demonstration of a surge in repolarization alternans magnitude preceding spontaneous ventricular arrhythmias in humans.
16. Kaufman ES, Mackall JA, Julka B, et al. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am J Physiol Heart Circ Physiol 2000; 279:H1248-H1255.
17. Hohnloser SH, Klingenheben T, Zabel M, et al. T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol 1997; 8:987-993.
18. Rashba EJ, Cooklin M, MacMurdy K, et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 2002; 105:837-842.
19. Komiya N, Seto S, Nakao K, Yano K. The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia. Pacing Clin Electrophysiol 2005; 28:680-684.
20. Klingenheben T, Gronefeld G, Li YG, Hohnloser SH. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 2001; 38:2013-2019.
21. Kavesh NG, Shorofsky SR, Sarang SE. The effect of procainamide on T wave alternans. J Cardiovasc Electrophysiol 1999; 10:649-654.
22. Groh WJ, Shinn TS, Engelstein EE, Zipes DP. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 1999; 10:1335-1339.
23. Nearing BD, Verrier RL. Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fibrillation. Circ Res 2002; 91:727-732.
24. Martinez JP, Olmos S, Wagner G, Laguna P. Characterization of repolarization alternans during ischemia: Time-course and spatial analysis. IEEE Trans Biomed Eng 2006; 53:701-711.
25. Kop WJ, Krantz DS, Nearing BD, et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation 2004; 109:1864-1869.
26. Verrier RL, Nearing BD, La Rovere MT, et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003; 14:705-711.
27. Bloomfield DM, Bigger JT, Steinman RC, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006; 47:456-463. Large prospective study of patients with an EF <40% that evaluated prognostic utility of TWA and controlled for confounding variables including LVEF.
28. Estes NA 3rd, Michaud G, Zipes DP, et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997; 80:1314-1318.
29. Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 2002; 92:541-549.
30. Verrier RL, Nearing BD, Kwaku KF. Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: Evidence and methodological guidelines. Ann Noninvasive Electrocardiol 2005; 10:110-120.
31. Narayan SM, Smith JM. Spectral analysis of periodic fluctuations in electrocardiographic repolarization. IEEE Trans Biomed Eng 1999; 46:203-212.
32. Raatikainen MJ, Jokinen V, Virtanen V, et al. Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol 2005; 28 (Suppl 1):S193-S197. Demonstrated the role of pacing in reducing indeterminate TWA results.
33. Rashba EJ, Osman AF, MacMurdy K, et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002; 13:845-850.
34. Bloomfield DM, Steinman RC, Namerow PB, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum. Circulation 2004; 110:1885-1889.
35. Chow T, Kereiakes DJ, Bartone C, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 2006; 47:1820-1827. The largest single study to date of TWA assessment in patients with ischemic cardiomyopathy. TWA remained a significant independent predictor of all cause and arrhythmic mortality after controlling for LVEF and ICD status.
36. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg cardiomyopathy study. Circulation 2003; 108:2883-2891.
37. Hohnloser SH, Klingenheben T, Bloomfield D, et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 2003; 41:2220-2224.
38. Jouven X, Zureik M, Desnos M, et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000; 343:826-833.
39. Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol 2003; 42:823-830.
40. Lauer MS, Okin PM, Larson MG, et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham heart study. Circulation 1996; 93:1520-1526.
41. Khan MN, Pothier CE, Lauer MS. Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol). Am J Cardiol 2005; 96:1328-1333.
42. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham heart study. Circulation 2003; 107:2920-2925.
43. Huikuri HV, Mahaux V, Bloch-Thomsen P. Cardiac arrhythmias and risk stratification after myocardial infarction: Results of the CARISMA pilot study. Pacing Clin Electrophysiol 2003; 26:416-419.
44. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial investigators. N Engl J Med 2000; 342:1937-1945.
45. Klingenheben T, Ptaszynski P, Hohnloser SH. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure. J Cardiovasc Electrophysiol 2005; 16:620-624. Demonstrated the prognostic utility of quantifying T wave alternans magnitude.
46. Tanno K, Ryu S, Watanabe N, et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: A prospective study using atrial pacing. Circulation 2004; 109:1854-1858.
47. Kitamura H, Ohnishi Y, Okajima K, et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2002; 39:295-300.
48. Chan PS, Stein K, Chow T, et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J Am Coll Cardiol 2006; 48:112-121. Cost-effectiveness analysis showing that the strategy of ICD implantation only in MADIT II eligible patients who have a non negative TWA test resulted in an incremental cost effectiveness comparable to hemodialysis.
49. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006; 295:1907-1911.
50. Iwasa A, Hwa M, Hassankhani A, et al. Abnormal heart rate turbulence predicts the initiation of ventricular arrhythmias. Pacing Clin Electrophysiol 2005; 28:1189-1197.
51. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998; 98:1510-1516.